Simplify Logo

Full-Time

Senior Manager

Patient Engagement, Enrollment and Retention

Posted on 3/29/2024

Verve Therapeutics

Verve Therapeutics

201-500 employees

Develops gene editing therapies for cardiovascular disease

Biotechnology
Healthcare

Senior

Boston, MA, USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Communications
Requirements
  • B.S/B.A. degree in a science-related field; advance degree preferred
  • 5+ years of clinical research / project management experience including clinical site, CRO, and/or sponsor experience
  • Experience managing vendor relationships, timelines, and budgets.
  • Strategic and creative thinking for patient recruitment and retention materials and efforts for global clinical trials
  • Ability to quickly pivot and implement alternate strategies within a changing study, program, or company landscape
  • Ability to work in a fast-paced environment with the ability to prioritize and manage multiple competing tasks and demands while ensuring overall quality and integrity
  • Foster open, available, and transparent communication
  • Strong interpersonal skill set necessary to develop, guide, and maintain internal and external collaborator relationships
  • Facilitate productive dialogue that empowers others to share input / recommendations / perspective, while driving the group to make a decision or take a position
  • Highly developed written and verbal communication skills, including presentation skills, ability to effectively articulate highly technical or complex concepts to audiences with differing levels of experience.
  • Attention to detail, strong organizational skills, and the ability to work individually, within a multi-disciplinary team, as well as with external partners and vendors.
Responsibilities
  • Support trial teams as the subject matter expert to develop and execute study-specific recruitment and retention strategies.
  • Oversee study-specific, patient enrollment-related initiatives, and vendor management to ensure they are run efficiently, tracked appropriately, and monitor the results to identify strategic changes and implement these changes for continued impact.
  • Bring the patient voice and experience into clinical development process in partnership with cross-functional teams, including Patient Advocacy and Clinical Development
  • Support trial teams as it relates to the assessment and incorporation of patient input into protocols, consent documents, and recruitment materials to influence trial design and early operational strategy with the goal of generating data to support executable, patient-friendly trial designs and assessments / outcome measures
  • Assist with the development and implementation of diversity plans to support teams with achieving enrollment of underrepresented patient population(s) that align with epidemiology of the target indication
  • Contribute to the continuity and connectivity between existing program/trial feasibility efforts and development of recruitment and retention plans by R&R vendor(s)
  • Support overall trial planning by confirming R&R vendor(s) is leveraging feasibility outputs, patient input and other available information when developing patient recruitment and retention strategy
  • Partner with Clinical Operations, Clinical Development, Medical Affairs, CRO teams, and other key stakeholders to carry out recruitment & retention plans, engage and support sites with local recruitment efforts, and implement innovative recruitment / retention tactics including social, digital, and long-term patient engagement initiatives
  • Assist with resolving issues and barriers, to support successful recruitment and retention of patients and confirm these are addressed by the R&R vendor(s)
  • Lead efficient and timely review of recruitment & retention materials
  • Support process improvement across the R&R space; provide input regarding quality of deliverables and performance of R&R vendors
  • Explore patient recruitment and retention vendors to identify services which will support patient recruitment and retention strategies
  • Evaluate proposals/tactics from recruitment vendors and CROs to ensure delivery of initiatives is covered from start to finish
  • Other duties as assigned

Verve Therapeutics focuses on developing gene editing treatments for cardiovascular disease. Their approach involves creating single-course therapies that aim to provide lasting solutions rather than ongoing treatments. The company specifically targets the PCSK9 and ANGPTL3 genes, which are known to help lower blood lipid levels. This focus on gene editing sets Verve apart from traditional therapies that require continuous management. The goal of Verve Therapeutics is to offer potentially curative options for patients with cardiovascular conditions, improving their long-term health outcomes.

Company Stage

IPO

Total Funding

$419.3M

Headquarters

Cambridge, Massachusetts

Founded

2018

Growth & Insights
Headcount

6 month growth

8%

1 year growth

9%

2 year growth

37%
Simplify Jobs

Simplify's Take

What believers are saying

  • Significant financial backing, including a $63 million Series A2 financing and $60 million from Eli Lilly, positions Verve for robust R&D and clinical trial activities.
  • The potential for a 'one-and-done' treatment for cardiovascular diseases could revolutionize the field and offer a high-impact, life-saving solution.
  • Early-stage success and strategic partnerships could lead to lucrative licensing deals and further investment opportunities.

What critics are saying

  • The clinical-stage nature of Verve's therapies means they are still years away from potential market approval, posing a long-term risk.
  • The recent stock price drop following a public offering indicates market volatility and potential investor uncertainty.

What makes Verve Therapeutics unique

  • Verve Therapeutics focuses on gene-editing therapies specifically for cardiovascular diseases, setting it apart from other CRISPR-based companies that target a broader range of conditions.
  • Their 'one-and-done' gene-editing approach aims to provide a single, curative treatment, which is a significant advantage over traditional, ongoing therapies.
  • Partnerships with major pharmaceutical companies like Eli Lilly enhance their credibility and provide substantial financial and research support.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE